PPAR-α attenuated cisplatin-induced acute renal failure (ARF) in mice by blocking fatty acid (FAs) oxidation inhibition, lowering apoptosis and necrosis in the proximal tubule [69], and controlling inflammation by inhibiting the NF-kB pathway [70]. The gene discussed is PPARA; the disease is acute kidney injury.